EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma

Se Un Jeong iD, Ja-Min Park iD, Sun Young Yoon iD, Hee Sang Hwang iD, Heounjeong Go iD, Dong-Myung Shin iD, Hyein Ju iD, Chang Ohk Sung iD, Jae-Lyun Lee iD, Gowun Jeong iD, Yong Mee Cho iD

Investigative and Clinical Urology · 2024 · 65 (1) · 84

DOI: 10.4111/icu.20230294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative and Clinical Urology, 2024. Verfasst von Se Un Jeong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Membrane Proteins, RNA-Binding Proteins, Tyrosine Kinase Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MSIP, Asan Institute for Life Sciences, Asan Medical Center, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellMembrane ProteinsRNA-Binding ProteinsTyrosine Kinase InhibitorsDrug Resistance, NeoplasmHumansSunitinibTNF Receptor-Associated Factor 6Transcription Factor AP-1Vascular Endothelial Growth Factor A

Stichwörter der Autor:innen

Carcinoma, renal cellDrug resistanceIFITM3 protein, humanMitogen-activated protein kinase 1TNF receptor-associated factor 6

Substanzen

IFITM3 protein, humanMembrane ProteinsRNA-Binding ProteinsSunitinibTNF Receptor-Associated Factor 6Transcription Factor AP-1Vascular Endothelial Growth Factor ATyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pathology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • AI Recommendation, T3K, SK Telecom, Seoul, Korea.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. yongcho@amc.seoul.kr.

ORCID-Profile: Se Un Jeong, Ja-Min Park, Sun Young Yoon, Hee Sang Hwang, Heounjeong Go, Dong-Myung Shin, Hyein Ju, Chang Ohk Sung, Jae-Lyun Lee, Gowun Jeong, Yong Mee Cho

Förderung

  • MSIP
  • Asan Institute for Life Sciences, Asan Medical Center
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Jeong, S. U., Park, J. M., Yoon, S. Y., Hwang, H. S., Go, H., Shin, D. M., Ju, H., Sung, C. O., Lee, J. L., Jeong, G., & Cho, Y. M. (2024). IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma. Investigative and Clinical Urology, 65(1), 84. https://doi.org/10.4111/icu.20230294

Vancouver

Jeong SU, Park JM, Yoon SY, Hwang HS, Go H, Shin DM, et al. IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma. Investigative and Clinical Urology. 2024;65(1):84. doi:10.4111/icu.20230294

BibTeX
@article{Jeong2024,
  author = {Jeong, Se Un and Park, Ja-Min and Yoon, Sun Young and Hwang, Hee Sang and Go, Heounjeong and Shin, Dong-Myung and Ju, Hyein and Sung, Chang Ohk and Lee, Jae-Lyun and Jeong, Gowun and Cho, Yong Mee},
  title = {IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma},
  journal = {Investigative and Clinical Urology},
  year = {2024},
  volume = {65},
  number = {1},
  pages = {84},
  doi = {10.4111/icu.20230294}
}
Kostenlos starten →